Latest / Your Daily Dose / A NEW BLOOD TEST FOR ALZHEIMERS
Transcript
- 0:00Speaker 1: Hey everybody, welcome. It's 9-9-26. September already rolling along. Today
- 0:07Speaker 1: we're going to talk about a new article that came
- 0:09Speaker 1: out in the Journal of Dementia and Alzheimer's, a new
- 0:11Speaker 1: blood test. It may help to detect Alzheimer's years before.
- 0:15Speaker 1: Tell me that isn't a test you'd like to have done.
- 0:18Speaker 1: We'll get involved in that and get some details. Stay tuned.
- 0:20Speaker 1: Hi and welcome to Health Talk with Dr. Len, your
- 0:23Speaker 1: daily dose. The information you hear on this show is informational.
- 0:26Speaker 1: It's not meant to diagnose or treat any disease. Any
- 0:30Speaker 1: kind of complete health conditions must be checked out and
- 0:35Speaker 1: discussed with your primary care physician. Get ready for the
- 0:38Speaker 1: good news of the day. God bless you folks. And
- 0:42Speaker 1: here is Dr.
- 0:43Speaker 2: Lin.
- 0:45Speaker 1: Our daily devotional today comes from the book of Isaiah
- 0:47Speaker 1: chapter 26. Walk with me along the paths of trust.
- 0:51Speaker 1: The most direct route between point A and point B
- 0:54Speaker 1: on your life journey is the path of unwavering trust
- 0:57Speaker 1: in me. When your faith falters, You choose a trail
- 1:00Speaker 1: that meanders and takes you well out of your way.
- 1:03Speaker 1: You will get to point B eventually, but you have
- 1:06Speaker 1: lost precious time and energy. As soon as you realize
- 1:09Speaker 1: you've wandered from your trust path, look to me and whisper,
- 1:12Speaker 1: I trust you, Jesus. This affirmation will get you back
- 1:15Speaker 1: on track. The farther you roam along the paths of unbelief,
- 1:19Speaker 1: the harder it is to remember that I am with you.
- 1:22Speaker 1: Anxious thoughts branch off in all directions, taking you farther
- 1:25Speaker 1: and farther from awareness of my presence. You need to
- 1:29Speaker 1: voice your trust in me frequently. This simple act of
- 1:32Speaker 1: faith will keep you walking along straight paths with me.
- 1:36Speaker 1: Trust in me with all your heart, and I will
- 1:38Speaker 1: make your paths straight.
- 1:41Speaker 2: I love it.
- 1:41Speaker 1: Stay tuned. Thank you.
- 2:36Speaker 2: 727-916-4215 When memory problems begin, One of.
- 3:05Speaker 1: The hardest questions for patients' families is whether they reflect
- 3:08Speaker 1: normal aging or the early stages of Alzheimer's disease. For decades,
- 3:13Speaker 1: confronting Alzheimer's disease meant a spinal tap or an expensive
- 3:17Speaker 1: brain scan. Now, a simple blood draw, the kind used
- 3:20Speaker 1: for routine checkups, can flag the disease telltale signs years
- 3:24Speaker 1: before memory loss ever appears. The shift gained new weight
- 3:28Speaker 1: with the recent FDA authorization of certain Alzheimer's blood tests.
- 3:32Speaker 1: a milestone that experts said could make evaluation more accessible,
- 3:36Speaker 1: one that arrives alongside new disease-modifying treatments for early-stage patients.
- 3:41Speaker 1: Early detection of Alzheimer's disease can provide access to disease-modifying therapies,
- 3:45Speaker 1: such as amyloid-treating treatments, currently available only for mild cognitive
- 3:51Speaker 1: impairment or mild dementia due to Alzheimer's. However, the same
- 3:55Speaker 1: experts who welcomed the tests are urging caution about who
- 3:58Speaker 1: should get one and why. The test looks for biomarkers,
- 4:02Speaker 1: proteins in the blood that single changes that are happening
- 4:05Speaker 1: in the brain, including amyloid beta, a protein that causes
- 4:09Speaker 1: abnormal buildup in the brain, tau, T-A-U, a protein that
- 4:13Speaker 1: helps support nerve cells, phosphorylated tau, modified forms of tau
- 4:18Speaker 1: that are closely linked to Alzheimer's, gliofibrillary acetic protein, a
- 4:24Speaker 1: marker of inflammation in the brain's support cells, neurofilament light chains,
- 4:30Speaker 1: a protein release when nerve cells are damaged, which may
- 4:32Speaker 1: indicate ongoing neurodegeneration. Still, researchers caution that these markers capture
- 4:37Speaker 1: downstream effects, not root causes. We do not yet know
- 4:40Speaker 1: what the earliest change in Alzheimer's disease is, said George Perry,
- 4:44Speaker 1: a professor of neurobiology at the University of Texas, San Antonio.
- 4:48Speaker 1: Tao helps to identify Alzheimer's-related brain changes in people who
- 4:53Speaker 1: are already showing cognitive symptoms. He says, however, researchers believe
- 4:58Speaker 1: The disease begins with other biological changes such as oxidative
- 5:01Speaker 1: stress and mitochondrial dysfunction, for which reliable biomarkers have yet
- 5:05Speaker 1: to be established. I will take aim with that one.
- 5:10Speaker 1: By measuring subtle changes in proteins such as PTAL217 and MLA-beta,
- 5:15Speaker 1: newer blood tests can estimate whether the brain has markers
- 5:17Speaker 1: of Alzheimer's. A 2024 study of 1,213 people undergoing evaluation
- 5:23Speaker 1: for memory and cognitive issues found that these tests were
- 5:27Speaker 1: 88 to 92% accurate. A study of 1,759 participants found
- 5:33Speaker 1: that blood testing could match the accuracy of spinal fluid
- 5:35Speaker 1: analysis up to 95% of the people with early symptoms.
- 5:39Speaker 1: Despite the accuracy of figures, experts agree that a blood
- 5:42Speaker 1: test alone cannot diagnose Alzheimer's. The biggest concern is misinterpretation,
- 5:47Speaker 1: said Dr. David Perlmutter, a board-certified neurologist and author of
- 5:52Speaker 1: Brain Defenders. A false positive may cause unnecessary fear, while
- 5:57Speaker 1: a false negative may provide false reassurance. These tests should
- 6:01Speaker 1: be used with counseling and clinical context. Perry drew a
- 6:05Speaker 1: comparison to a familiar and famously imperfect screening tool. I
- 6:10Speaker 1: see Alzheimer's disease blood tests such as PSA. The positive
- 6:15Speaker 1: results indicate a departure from normal, but does not necessarily
- 6:18Speaker 1: mean a person has the disease, in this case, prostate cancer.
- 6:22Speaker 1: Blood tests could serve as a useful baseline measure, but
- 6:24Speaker 1: their limitations need to be better understood. That's why Perry
- 6:28Speaker 1: cautions about using these tests to screen the general population.
- 6:32Speaker 1: False positives can push cognitively healthy people toward unnecessary or
- 6:35Speaker 1: risky treatments to prevent a disease they may not have
- 6:39Speaker 1: ever gotten. Their stronger near-term use may be in studying Alzheimer's,
- 6:44Speaker 1: defining patient population and measuring the effectiveness of different treatments.
- 6:49Speaker 1: These tests can be viewed as part of a broader
- 6:51Speaker 1: clinical evaluation alongside symptoms, family history, Cognitive testing, medication, sleep, mood,
- 6:57Speaker 1: vascular changes, metabolic health markers, and possible causes of cognitive problems.
- 7:03Speaker 1: Depending on the blood test and symptoms assessment, treating with
- 7:06Speaker 1: cerebral spinal fluid or PET imaging may still need to
- 7:10Speaker 1: be appropriate. Good Lord, there is so much when we
- 7:15Speaker 1: talk about mitochondrial dysfunction and dimethylglycine and brain support, and
- 7:20Speaker 1: you get down the list of the nutritional problems factors
- 7:23Speaker 1: that are there if you have somebody in your family
- 7:25Speaker 1: friends relatives that are showing these early signs it's never
- 7:30Speaker 1: too soon to actually get a protocol put together with
- 7:32Speaker 1: them if you need help with that give me a
- 7:34Speaker 1: call 727-916-4215 god bless folks